Results 231 to 240 of about 6,580,070 (356)
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla +13 more
wiley +1 more source
Reforming China's Rare Disease Security System: Risk Management Perspectives and a Dedicated Insurance Innovation. [PDF]
Zhang Y, Yang M, Su Q, Sui Y, Sun L.
europepmc +1 more source
Global Financial Crisis and Risk Management in Financial Intermediaries: Is it White Page?
Yener Çoşkun, Murad Kayacan
openalex +1 more source
A Twist in the Diagnosis: Chronic Arthropathy Without Inflammation
Arthritis Care &Research, EarlyView.
María Á. Puche‐Larrubia +3 more
wiley +1 more source
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England +9 more
wiley +1 more source
From perception to modelling: Nature-based solutions as a tool for coastal risk management. [PDF]
d'Avdeew M +5 more
europepmc +1 more source
Objectives Reports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community‐dwelling individuals aged 70 and older.
Amanda J Rickard +15 more
wiley +1 more source
Tracking a Medicine's Regulatory Risk Management Commitments Provides Better Transparency and Oversight. [PDF]
Ingate S +5 more
europepmc +1 more source

